West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc.

Overview
Date Founded

1923

Headquarters

530 HERMAN O. WEST DRIVE, EXTON, PA, 19341

Type of Company

Public

Employees (Worldwide)

8,200

Industries

Medical Products & Equipment
Biotechnology
Hospitals & Patient Services

Company Description

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Contact Data
Trying to get in touch with decision makers at West Pharmaceutical Services Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer, Treasurer & Senior Vice President

Senior Vice President, General Counsel & Secretary

Vice President & Chief Technology Officer

Senior Vice President & Chief Human Resources Officer

Vice President, Chief Accounting Officer & Corporate Controller

President-Drug Delivery Systems Division

Senior Vice President, Commercial Products & Emerging Markets

Senior Vice President, Chief Operations & Supply Chain Officer

Senior Vice President, Global Market Units & Commercial Solutions

Board of Directors

Former Executive Chairman of the Board & Interim Chief Executive Officer at EXACT Sciences Corp.

President at Wellesley College

Former President & Chief Executive Officer at PerkinElmer, Inc.

Chief Executive Officer & Director at Certara USA, Inc.

Former President, Chief Executive Officer & Director at OraSure Technologies, Inc.

Vice Chairman at The Fox Chase Cancer Center Foundation

Former President at Bayer AG

Paths to West Pharmaceutical Services Inc.
Potential Connections via
Relationship Science
You
West Pharmaceutical Services Inc.
Owners & Shareholders
Details Hidden

Franklin Advisers' accounts utilize various investment strategies including, but not limited to, equity, fixed income, core, hybrid, and multi-asset strategies. Their investment management services incorporate fundamental investment research and valuation analyses, including original economic, political, industry and company research, and analyses of suppliers, customers and competitors. The sources they use for their company research include company public records and other publicly available information, management interviews, company-prepared information, and company visits and inspections. Franklin Advisers' investment strategies include US and global fixed income; franklin core and hybrid; franklin dividend growth; franklin US growth equity; franklin sector strategies; and multi-asset strategies.

Details Hidden

NBIA offers advices on a wide range of fixed-income securities and other financial instruments. The firm's fixed-income strategies may also hold cash and cash equivalents. Investments may be denominated in currencies other than the US dollar. NBIA may use derivative instruments for hedging and non-hedging purposes. They provide investment management services based on a variety of fixed income strategies including, but not limited to: investment grade, municipal securities, non-investment grade, emerging market debt, and residential loan modification. NBIA offers advice on a variety equity security. Like fixed-income strategy, equity strategies may also hold cash and cash equivalents, investments may be denominated in currencies other than the US dollar, and may use investments in derivative instruments for hedging and non-hedging purposes. NBIA also offers alternative strategies that are managed by teams that specialize in alternative investing. Those strategies may invest in a wide variety of equity, fixed income, and other instruments and may incorporate NBIA's elements of equity and fixed income strategies or leverage the research from these strategies. These strategies may involve long-only investing or a combination of long and short investment, which may involve the use of derivatives and leverage. NBIA also manages Multi-Asset Mandates that may combine certain of the fixed income and equity strategies.

Details Hidden

BAMCO's investment strategy is to invest in growth businesses for capital appreciation potential. Each portfolio manager's ability to choose appropriate investments for an account has a significant impact on their ability to achieve an account's investment objective. The firm's investment professionals are focused on fundamental analyses of businesses. Their primary objective is to understand the key drivers of growth and profitability of each company in which they invest. They analyze the following financial information: income statement, cash flow statement, balance sheet, turnover and ROE metrics, unit economics, and other company-specific data. This information is filtered through their valuation models, which they use to extrapolate long-term trends. They have meetings with the management which is a critical element of the firm's research process.

Recent Transactions
Details Hidden

West Pharmaceutical Services Inc. purchases La Model Ltd.

Details Hidden

West Pharmaceutical Services Inc. purchases Plastef Investissements SAS from Naxicap Partners SA

Details Hidden

Covance, Inc. purchases GFI Clinical Services from West Pharmaceutical Services Inc. resulting in a new company Covance GFI Research

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onWest Pharmaceutical Services Inc. purchases Tech Group, Inc. /Manufacturing Operations from TGI Holdings, Inc.

Accountant

Advised onWest Pharmaceutical Services Inc. purchases Tech Group, Inc. /Manufacturing Operations from TGI Holdings, Inc.

Investment Advisor

Advised onWarburg Pincus LLC purchases West Pharmaceutical Services, Inc. /Drug Delivery Business from West Pharmaceutical Services Inc.

Legal Advisor

Advised onWest Pharmaceutical Services Inc. purchases Tech Group, Inc. /Manufacturing Operations from TGI Holdings, Inc.

Advisors & Consultants
Advisor

Former Chief Financial Officer, Treasurer & Senior Vice President at West Pharmaceutical Services Inc.

Legal Advisor

Partner, Privacy, Security & Information at Field Fisher Waterhouse LLP

Legal Advisor

Former Partner at Dechert LLP

Key Stats and Financials As of 2019
Market Capitalization
$17B
Total Enterprise Value
$11.2B
Earnings Per Share
$3.21
Revenue
$1.84B
Total Equity
$1.57B
EBITDAMargin
21.73%
Enterprise Value Sales
6.09x
Enterprise Value EBITDAOperating
27.84x
TEVNet Income
46.44x
Debt TEV
0.03x
Total Debt
$329M
EBITDA
$401M
Net Profit
$242M
Three Year Compounded Annual Growth Rate Of Revenue
6.9%
Five Year Compounded Annual Growth Rate Of Revenue
5.33%
Non-Profit Donations & Grants
Investments
Details Hidden

NanoPass Technologies Ltd. develops and manufactures pharmaceuticals. It offers MicronJet needle which is a painless Intradermal Injection. The company was founded by Shuki Yeshurun in 2000 and is headquartered in Nes Ziona, Israel.

Details Hidden

Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by West Pharmaceutical Services Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of West Pharmaceutical Services Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and West Pharmaceutical Services Inc..